- Stocks
- Healthcare
- NASDAQ: CDXS

Price (delayed)

$2.73

Market cap

$193.63M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.08

Enterprise value

$215.99M

CDXS's gross margin is up by 6% year-on-year but it is down by 5% since the previous quarter

The equity has dropped by 50% year-on-year and by 22% since the previous quarter

CDXS's revenue is down by 39% year-on-year and by 18% since the previous quarter

What are the main financial stats of CDXS

Market
Valuations
Earnings

Shares outstanding

70.93M

Market cap

$193.63M

Enterprise value

$215.99M

Price to earnings (P/E)

N/A

Price to book (P/B)

3.13

Price to sales (P/S)

3.16

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.55

Revenue

$60.89M

EBIT

-$75.31M

EBITDA

-$66.77M

Free cash flow

-$48.37M

Per share
Balance sheet
Liquidity

EPS

-$1.08

Free cash flow per share

-$0.69

Book value per share

$0.87

Revenue per share

$0.87

TBVPS

$1.84

Total assets

$132.01M

Total liabilities

$70.56M

Debt

$42.54M

Equity

$61.45M

Working capital

$60.86M

Debt to equity

0.69

Current ratio

2.99

Quick ratio

2.75

Net debt/EBITDA

-0.33

Margins
Efficiency
Dividend

EBITDA margin

-109.7%

Gross margin

77.9%

Net margin

-125.4%

Operating margin

-109%

Return on assets

-53.3%

Return on equity

-95.8%

Return on invested capital

-92%

Return on capital employed

-74.2%

Return on sales

-123.7%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Codexis stock price performed over time

Intraday

0%

1 week

-2.85%

1 month

-3.19%

1 year

56%

YTD

-10.49%

QTD

-11.94%

How have Codexis's revenue and profit performed over time

Revenue

$60.89M

Gross profit

$47.46M

Operating income

-$66.4M

Net income

-$76.36M

Gross margin

77.9%

Net margin

-125.4%

The net margin has plunged by 119% YoY and by 43% from the previous quarter

The operating margin has dropped by 80% year-on-year and by 44% since the previous quarter

CDXS's revenue is down by 39% year-on-year and by 18% since the previous quarter

Codexis's gross profit has decreased by 35% YoY and by 22% QoQ

What is Codexis's growth rate over time

What is Codexis stock price valuation

P/E

N/A

P/B

3.13

P/S

3.16

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.55

The EPS has declined by 27% year-on-year and by 16% since the previous quarter

The equity has dropped by 50% year-on-year and by 22% since the previous quarter

CDXS's price to book (P/B) is 46% lower than its 5-year quarterly average of 5.8 but 20% higher than its last 4 quarters average of 2.6

The price to sales (P/S) is 65% lower than the 5-year quarterly average of 9.1 but 9% higher than the last 4 quarters average of 2.9

CDXS's revenue is down by 39% year-on-year and by 18% since the previous quarter

How efficient is Codexis business performance

Codexis's return on equity has shrunk by 132% YoY and by 40% QoQ

The return on sales has dropped by 117% year-on-year and by 41% since the previous quarter

Codexis's return on assets has shrunk by 114% YoY and by 33% QoQ

The company's return on invested capital has shrunk by 99% YoY and by 13% QoQ

What is CDXS's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CDXS.

How did Codexis financials performed over time

CDXS's total assets is 87% greater than its total liabilities

CDXS's total assets is down by 36% year-on-year and by 12% since the previous quarter

Codexis's current ratio has decreased by 19% QoQ and by 11% YoY

The debt is 31% less than the equity

The company's debt to equity has surged by 109% YoY and by 25% QoQ

The equity has dropped by 50% year-on-year and by 22% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.